Travis Thompson’s 58,000‑Share Option Exercise Signals Bold Optimism for Bicycle Therapeutics
Insider CFO Travis Thompson’s 58,000‑share option exercise reveals mixed signals: short‑term liquidity versus long‑term confidence in Bicycle Therapeutics’ oncology and radiopharma pipeline, a key factor for investors watching potential rebound afte…
3 minutes to read